Scores of people experience complications after change from Tysabri to Tyruko as part of NHS drive to save money
‘It was awful for me’: one MS patient shares her experience with Tyruko
Scores of people with multiple sclerosis (MS) have suffered debilitating side-effects after being put on to a cheaper new drug as part of an NHS drive to save money.
About 170 MS patients at Charing Cross hospital in London have had complications, including a relapse of their illness, after being switched from Tysabri to a different drug called Tyruko, made by the pharmaceutical company Sandoz.
About Author
More Stories
Revealed: Chinese researchers can access half a million UK GP records
About 15% of world’s cropland polluted with toxic metals, say researchers
Rebecca Hendin on life outside our solar system – cartoon